Risk of immune-related diarrhea with PD-1/PD-L1 inhibitors in different cancer types and treatment regimens

Objective: To compare the incidence and severity of diarrhea among different tumor types and treatment regimens, and also compared with CTLA-4 inhibitors in randomized controlled trials. Methods: MEDLINE, PMC database and EMBASE were retrieved until December 2018. Studies were eligible if they were...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Lei, Yu, Jing, Wang, Jing, Li, Huihui, Che, Juanjuan, Cao, Bangwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930395/
https://www.ncbi.nlm.nih.gov/pubmed/31892971
http://dx.doi.org/10.7150/jca.32724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930395/
https://www.ncbi.nlm.nih.gov/pubmed/31892971
http://dx.doi.org/10.7150/jca.32724

Ejemplares similares